-
-
-
-
-
-
-
Amneal Receives U.S. FDA Approval for Epinephrine Injection in Single- and Multi-Dose Vials for U.S. Hospitals
-
-
-
-
-
-
-
Amneal gets FDA approval for first generic iohexol injection
-
-
-
-
-
-
-
Amneal to Report Third Quarter 2025 Results on October 30, 2025
-
-
-
-
-
-
-
Amneal receives FDA approval for generic risperidone injection
-
-
-
-
-
-
-
Amneal Reports Certain Preliminary Second Quarter 2025 Financial Results
-
-
-
-
-
-
-
Amneal Pharmaceuticals (AMRX) Receives U.S. FDA Approval for Brekiya
-
-
-
-
-
-
-
Amneal Pharmaceuticals (AMRX) Announces New Data from Phase 3 Study Showing Significant Improvements in Sleep Quality with CREXONT
-
1,168,522 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

